Anatara Lifesciences Ltd (AU:ANR) has released an update.
Anatara Lifesciences Ltd has reported a successful outcome from its General Meeting on July 5, 2024, with all shareholder resolutions approved by a clear majority on a poll. The resolutions included the ratification of share issues and the issuance of director options under the Executive Option Plan. The company’s shareholders demonstrated strong support for the proposed actions, indicating confidence in Anatara’s strategic direction.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.
